5th Annual Medical Affairs Leaders Forum Asia 2017

Topics

• What are the most intelligent ways to map and engage with Asian KOLs and other stakeholder groups such as, prescribers, payers, patient groups, pharmacies and tomorrows stakeholders
• How medical affairs are at the forefront of novel pharmaceutical industry commercial models in Asia and what needs to be done to maximise success
• How medical liaisons, in support of commercial teams, are crucial to the communication of effectiveness, safety and value in Asia
• What are best practices in late-phase research, especially observational studies, patient registries and investigator initiated studies across Asia
• What can be applied in key Asian markets - Learn from the experiences of global medical affairs experts
• Hear from industry experts experienced in setting up medical affairs departments in the Asian region and maximizing their performance

Who should Attend

Attendees from pharma and medical device companies:

• Late Phase, KOL & stakeholder engagement, Scientific Affairs, Clinical development, Customer Relations, Medical Advisors
• Regional & Global Directors, VPs and managers of Medical Science Liaisons, Medical Affairs, Health Outcome & Liaison, Medical Education and Medical Marketing & Communications from pharma and medical device companies